TPBG

TPBG

Target · Oncofetal antigen

TPBG Trophoblast glycoprotein · 5T4 oncofetal antigen

TPBG (trophoblast glycoprotein, also known as 5T4 or 5T4-AG) is a leucine-rich transmembrane glycoprotein on the cell membrane. It is an oncofetal antigen specific to trophoblast cells and may act in cell adhesion and in the regulation of Wnt signalling. Browse Assay Genie's current range of TPBG research reagents below, or read on for the biology behind the target.

Cell membrane glycoproteinLeucine-rich transmembrane proteinOncofetal tumour antigen
420 aa
Protein length
~46 kDa
Molecular weight
6q14.1
Gene locus
LRR glycoprotein
Protein family
Target information

What is TPBG (trophoblast glycoprotein)?

TPBG, or trophoblast glycoprotein, is a transmembrane protein located at the cell membrane. UniProt annotates it as a possible inhibitor of Wnt/beta-catenin signalling: it may interact indirectly with LRP6 and block Wnt3a-dependent internalisation of LRP6. NCBI Gene also describes the protein as potentially involved in cell adhesion.

The TPBG gene encodes a leucine-rich glycoprotein. Alternate splicing in the 5' UTR produces multiple transcript variants, but all of them encode the same TPBG protein. The mouse and rat orthologues are both named Tpbg, which allows the protein to be studied in common rodent models.

TPBG is best known as an oncofetal antigen. It is specific to trophoblast cells during development, which accounts for its name. In adults it is highly expressed in many tumour cells, and RefSeq notes an association between TPBG and poor clinical outcome in numerous cancers. The 5T4 and 5T4-AG aliases reflect its identification as a tumour-associated antigen, and researchers working on TPBG often search under these names. This combination of restricted normal expression and high tumour expression makes TPBG a frequent subject in cancer biology and in studies of Wnt pathway regulation.

Cancer biology

TPBG is highly expressed in many tumour cells and is associated with poor clinical outcome in numerous cancers.

Oncofetal antigen studies

As an oncofetal antigen specific to trophoblast cells, TPBG is used to explore links between development and tumour biology.

Wnt signalling research

TPBG may inhibit Wnt/beta-catenin signalling by indirectly interacting with LRP6 and blocking Wnt3a-dependent LRP6 internalisation.

Cell adhesion studies

This leucine-rich transmembrane glycoprotein may be involved in cell adhesion, making it relevant to membrane protein research.

Background

TPBG frequently asked questions

What does TPBG do?

TPBG may function as an inhibitor of Wnt/beta-catenin signalling. UniProt reports that it indirectly interacts with LRP6 and blocks Wnt3a-dependent LRP6 internalisation. NCBI Gene adds that this leucine-rich transmembrane glycoprotein may also be involved in cell adhesion.

What other names does TPBG go by?

TPBG is the HGNC symbol for trophoblast glycoprotein. It is also known as 5T4 and 5T4-AG. Alternate splicing in the 5' UTR gives multiple transcript variants, but they all encode the same protein, so there are no distinct protein isoforms.

Is TPBG linked to cancer, and is it conserved in rodents?

TPBG is an oncofetal antigen, specific to trophoblast cells and highly expressed in many adult tumour cells. It is associated with poor clinical outcome in numerous cancers. Mouse and rat both have a Tpbg orthologue; check the datasheet of any product for its validated reactivity.

Explore

Related targets

Wnt pathway components and tumour-associated antigens that sit alongside TPBG in cancer and signalling research.

Gene and protein annotations from HGNC, NCBI Gene and UniProt Q13641; product specifications from Assay Genie datasheets.

TPBG Product listing